SL
ORIC icon

Siren LLC’s Oric Pharmaceuticals ORIC Stock Holding History

Siren LLC’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.5M Hold
2,998,192
– – 0.66% 42
2026
Q1 		$38M Buy
2,998,192
+1,990,617
+198% +$22.6M 1.05% 29
2025
Q4 		$8.24M Hold
1,007,575
– – 0.25% 56
2025
Q3 		$12.1M Hold
1,007,575
– – 0.47% 45
2025
Q2 		$10.2M Hold
1,007,575
– – 0.53% 40
2025
Q1 		$5.62M Hold
1,007,575
– – 0.32% 54
2024
Q4 		$8.13M Hold
1,007,575
– – 0.36% 54
2024
Q3 		$10.3M Buy
+1,007,575
New +$9.96M 0.52% 43

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Siren LLC's ORIC Position: Q2 2026 in Review

Siren LLC held its Oric Pharmaceuticals (ORIC) position steady in Q2 2026 at 2,998,192 shares worth $32.5M. The position accounts for 0.66% of the portfolio, ranked #42.

Siren LLC first reported a position in ORIC in Q3 2024 and has held it in 8 quarters since. The position peaked at $38M in Q1 2026. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Siren LLC held 2,998,192 shares of Oric Pharmaceuticals worth $32.5M as of Q2 2026.
  • Siren LLC left its Oric Pharmaceuticals share count unchanged in Q2 2026.
  • Oric Pharmaceuticals made up 0.66% of Siren LLC's portfolio in Q2 2026, its #42 holding.
  • Siren LLC first reported a position in Oric Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Siren LLC's Oric Pharmaceuticals position peaked at $38M in Q1 2026.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Siren LLC's 13F filing for Q2 2026, filed 13 Aug 2026.